Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Impax Laboratories, Inc.

OKLAHOMA CITY--()--On November 10, 2016, a class action lawsuit was filed in the United States District Court for the District of New Jersey against Impax Laboratories, Inc. (NASDAQ: IPXL). Federman & Sherwood reminds current and former shareholders of Impax Laboratories, Inc. that they only have until Monday, January 9, 2017 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased Impax Laboratories, Inc. shares between February 24, 2014 and November 3, 2016, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible. Our firm seeks to recover damages on behalf of the Class. Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud. We represent investors throughout the country in shareholder litigation.

Contacts

Federman & Sherwood
William B. Federman, 405-235-1560
Fax: 405-239-2112
wbf@federmanlaw.com
www.federmanlaw.com

Recent Stories

RSS feed for Federman & Sherwood

Release Summary

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Impax Laboratories, Inc.

Federman & Sherwood